Olanzapine (LY170053) 50mg 50mg | Purity Not Available
Adooq Bioscience
Olanzapine(Zyprexa) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.
More Information Supplier PageSearch Results
Olanzapine (LY170053) 250mg 250mg | Purity Not Available
Adooq Bioscience
Olanzapine(Zyprexa) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.
More Information Supplier PageOlanzapine (LY170053) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Olanzapine(Zyprexa) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.
More Information Supplier PageOlanzapine (LY170053) 100mg 100mg | Purity Not Available
Adooq Bioscience
Olanzapine(Zyprexa) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.
More Information Supplier PageNVP-BHG712 10mg 10mg | Purity Not Available
Adooq Bioscience
NVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3.
More Information Supplier PageNVP-BEP800 5mg 5mg | Purity Not Available
Adooq Bioscience
NVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageNVP-BEP800 25mg 25mg | Purity Not Available
Adooq Bioscience
NVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageNVP-BEP800 100mg 100mg | Purity Not Available
Adooq Bioscience
NVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageNVP-BEP800 10mg 10mg | Purity Not Available
Adooq Bioscience
NVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageAUY922 5mg 5mg | Purity Not Available
Adooq Bioscience
AUY922 (NVP-AUY922) is highly potent and oral inhibitor of Hsp90 with IC50=21 nM in Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 average 9 nM.
More Information Supplier Page